PSTX

Poseida Therapeutics (PSTX)

About Poseida Therapeutics (PSTX)

Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of non-viral gene engineering technologies for the treatment of hematological malignancies and solid tumors. Its products pipeline include autologous and allogeneic chimeric antigen receptor T cell, or CAR-T. The company was founded by Eric M. Ostertag in December 2014 and is headquartered in San Diego, CA.

Details

Daily high

$2.52

Daily low

$2.41

Price at open

$2.51

52 Week High

$4.27

52 Week Low

$1.83

Market cap

248.7M

Dividend yield

0.00%

Volume

62,237

Avg. volume

585,757

P/E ratio

-2.16

Poseida Therapeutics News